Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 3/20 | 1.00 |
| ▸ | TSHR | P16473 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.56 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.56 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.48 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1793814 | 1.00 | AOC3 (1.00) | AOC3TSHRALDH1A1CARM1PRMT6 | |
| Hydrochloric Acid SCHEMBL4696173 | 0.97 | AOC3 (0.95) | AOC3TSHRALDH1A1CARM1PRMT6 | |
| Ammonia Solution, Strong SCHEMBL28459179 | 0.97 | AOC3 (0.95) | AOC3TSHRALDH1A1CARM1PRMT6 | |
| Hydrochloric Acid SCHEMBL11186055 | 0.97 | AOC3 (0.95) | AOC3TSHRALDH1A1CARM1PRMT6 | |
| Hydrazine SCHEMBL28353884 | 0.97 | AOC3 (0.95) | AOC3TSHRALDH1A1CARM1PRMT6 | |
| Bromide SCHEMBL28239009 | 0.95 | AOC3 (0.91) | AOC3TSHRALDH1A1CARM1PRMT6 | |
| SCHEMBL11750385 | 0.86 | AOC3 (0.75) | AOC3TSHRALDH1A1CARM1PRMT6 | |
| SCHEMBL28360424 | 0.81 | AOC3 (0.66) | AOC3TSHRALDH1A1CARM1PRMT6 | |
| Methylamine SCHEMBL27897983 | 0.79 | ALDH1A1 (0.90) | AOC3TSHRALDH1A1CARM1PRMT6 | |
| Hydrazine SCHEMBL28104560 | 0.79 | TSHR (0.90) | AOC3TSHRALDH1A1CARM1PRMT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116209439-B | Cereblon protein modulators | Saint Jude Children's Research Hospital Ltd. (US) | 2026-05-26 | — | — | CN | claimed |
| EP-3256420-B1 | USE OF MODIFIED AMINES SCALE INHIBITORS IN WET PROCESS PHOSPHORIC ACID PRODUCTION | CYTEC IND INC (US) | 2025-04-23 | — | — | EP | claimed |
| CN-119677539-A | Combination therapy for modulating lipid production | 俄亥俄州创新基金会 | 2025-03-21 | — | — | CN | claimed |
| CN-119546293-A | Combination of HDAC inhibitors and statins for the treatment of pancreatic cancer | 国家癌症研究所IRCCS-G·帕斯卡莱基金会 | 2025-02-28 | — | — | CN | claimed |
| CN-119403836-A | Methods for eliminating myeloid-derived suppressor cells using NEO-201 antibodies | 精密生物制品股份有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-114716548-B | Anti-FGFR 3 antibodies and uses thereof | (株)爱恩德生物 | 2024-11-05 | — | — | CN | claimed |
| CN-112041343-B | Methods and compositions for targeting Treg cells | 精密生物制品股份有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-118434765-A | BCMA monoclonal antibodies and antibody-drug conjugates | 杭州多禧生物科技有限公司 | 2024-08-02 | — | — | CN | claimed |
| CN-113646299-B | Novel N-benzyl-2-phenoxybenzamide derivatives as prostaglandin E2 (PGE 2) receptor modulators | 梅迪比奥法尔玛公司 | 2024-07-26 | — | — | CN | claimed |
| CN-118234748-A | Methods and compositions for treating hematological malignancies | 精密生物制品股份有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-1856469-A | Fluoro omega-carboxyaryl diphenyl ureas for the treatment and prevention of diseases and disease symptoms | BAYER PHARMACEUTICALS CORP (US) | 2006-11-01 | — | — | CN | claimed |
| WO-2006014367-A1 | FUNCTIONALIZED SILICON COMPOUNDS | HONEYWELL INTERNATIONAL INC. (US) | 2006-02-09 | — | — | WO | claimed |
| CN-1711076-A | Combination cancer therapy of a GST-activated anticancer compound and another anticancer therapy | TELIK INC (US) | 2005-12-21 | — | — | CN | claimed |
| CN-1646120-A | Antineoplastic combinations | WYETH CORP (US) | 2005-07-27 | — | — | CN | claimed |
| CN-1630516-A | Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents | UAB RESEARCH FOUNDATION (US) | 2005-06-22 | — | — | CN | claimed |
| CN-1496256-A | Combinations of epothilone (EPO THIONE) analogs and chemotherapeutic agents for the treatment of proliferative diseases | ����˹�ж�-����˹˹������˾ | 2004-05-12 | — | — | CN | claimed |
| CN-1088777-A | The preparation method that is used for the chemotherapeutic preparation of directly administering to cancer nidus | CONG FANZI (CN) | 1994-07-06 | — | — | CN | claimed |
| US-4617401-A | ANTISPASMODIC AGENTS, VASODILATORS | SUNTORY LTD. (JP) | 1986-10-14 | — | — | US | claimed |
| EP-0039903-B1 | 8-SUBSTITUTED PYRROLIZIDINES AND QUATERNARY AMMONIUM SALTS THEREOF | SUNTORY KABUSHIKI KAISHA (JP) | 1986-04-09 | — | — | EP | claimed |
| EP-0039903-A2 | 8-Substituted pyrrolizidines and quaternary ammonium salts thereof | SUNTORY KABUSHIKI KAISHA (JP) | 1981-11-18 | — | — | EP | claimed |